Keyphrases
8q24
5%
Age at Diagnosis
7%
Aggressive Prostate Cancer
10%
Association Study
5%
Biochemical Recurrence
6%
Biochemical Recurrence-free Survival
8%
Cancer Families
10%
Cancer Susceptibility Genes
5%
Clinically Significant Prostate Cancer
5%
Comorbidity
5%
Confidence Interval
6%
Erectile Dysfunction
8%
Erectile Function
6%
European Ancestry
8%
Familial Prostate Cancer
20%
Family History
20%
Genome-wide Association Study
7%
German Population
6%
Germany
11%
Hereditary Prostate Cancer
6%
Long-term Survivors
9%
Low Risk
5%
Male Sex
5%
Meta-analysis
6%
Nerve-sparing Radical Prostatectomy
7%
Odds Ratio
6%
Older Men
6%
Polygenic Risk Score
7%
Positive Family History
7%
Prostate
8%
Prostate Cancer
86%
Prostate Cancer Patients
16%
Prostate Cancer Risk
34%
Prostate Cancer Screening
11%
Prostate Cancer Survivors
12%
Prostate-specific Antigen
11%
Prostate-specific Antigen Testing
6%
Radical Prostatectomy
52%
Recurrent Disease
5%
Risk Factors
8%
Risk Loci
5%
Sex Studies
5%
SNP
5%
Sporadic Prostate Cancer
9%
Susceptibility Loci
12%
Urologists
8%
Medicine and Dentistry
Biochemical Recurrence Free Survival
7%
Biopsy Technique
7%
Cancer Risk
9%
Cancer Screening
8%
Cancer Susceptibility
9%
Comorbidity
6%
Disease
20%
Erectile Dysfunction
6%
Family History
19%
Lymph Node
5%
Malignant Neoplasm
9%
Neoplasm
7%
Pelvis
5%
Prevalence
5%
Prostate Cancer
100%
Prostate Specific Antigen
11%
Prostatectomy
53%
Retroperitoneal Lymph Node Dissection
5%
Urologist
8%
